beta
MTRY
Monterey Innovation Acquisition Corp
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
monterey bio (“mtryu”) is a specialty purpose acquisition company (spac) with the goal of effecting a merger, asset acquisition, or similar business combination with business targets that are developing or enabling development of pre-commercial therapeutic candidates across a broad array of therapeutic areas, with an initial focus on oncology and immunology.
Market Cap: 48.3 Million
Primary Exchange: NASDAQ
Website: montereybio.com
Shares Outstanding: 4.34 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector:
Industry:
Ethical Flags
Longest drawdown: 90 trading days
From: 2023-07-31 To: 2023-11-20
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|